All > Spinal Cord Injury > Sci

Exenatide 2 MG Injection [Bydureon] for Insulin Resistance

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Insulin Resistance+3 MoreExenatide 2 MG Injection [Bydureon] - Drug
Eligibility
18 - 69
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing whether a new medication can help people with spinal cord injury by improving glycemic control and inducing weight loss.

Eligible Conditions
  • Insulin Resistance
  • Spinal Cord Injury
  • Obesity
  • Prediabetes

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
L-NMMA
1
Atorvastatin and anakinra
1
Loratadine

Study Objectives

3 Primary · 2 Secondary · Reporting Duration: Baseline, Week 13, Week 26

Week 26
Body Fat
Body Weight
Glycated Hemoglobin (HbA1C)
Homeostatic Model Assessment of Beta-Cell Function (HOMA-B)
Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
L-NMMA
1
Atorvastatin and anakinra
1
Loratadine

Side Effects for

Exenatide
38%Death
This histogram enumerates side effects from a completed 2017 Phase 4 trial (NCT02058940) in the Exenatide ARM group. Side effects include: Death with 38%.

Trial Design

1 Treatment Group

Exenatide 2 MG Injection [Bydureon]
1 of 1

Experimental Treatment

30 Total Participants · 1 Treatment Group

Primary Treatment: Exenatide 2 MG Injection [Bydureon] · No Placebo Group · Phase 4

Exenatide 2 MG Injection [Bydureon]
Drug
Experimental Group · 1 Intervention: Exenatide 2 MG Injection [Bydureon] · Intervention Types: Drug

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, week 13, week 26

Who is running the clinical trial?

James J. Peters Veterans Affairs Medical CenterLead Sponsor
53 Previous Clinical Trials
3,001 Total Patients Enrolled
1 Trials studying Insulin Resistance
68 Patients Enrolled for Insulin Resistance
Kessler Institute for RehabilitationIndustry Sponsor
22 Previous Clinical Trials
1,190 Total Patients Enrolled

Eligibility Criteria

Age 18 - 69 · All Participants · 6 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top